SKU(재고 관리 코드):LMA303Ra
Magnetic Luminex Assay Kit for Galectin 3 (GAL3) ,etc.
Magnetic Luminex Assay Kit for Galectin 3 (GAL3) ,etc.
Product No.
LMA303Ra
Organism Species
Rattus norvegicus (Rat).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
4.88-5000pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 1.627 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Galectin 3 (GAL3) ,etc..
No significant cross-reactivity or interference between Galectin 3 (GAL3) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Galectin 3 (GAL3) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Galectin 3 (GAL3) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 78-104 | 94 |
EDTA plasma(n=5) | 96-103 | 99 |
heparin plasma(n=5) | 84-95 | 90 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Galectin 3 (GAL3) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Galectin 3 (GAL3) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Galectin 3 (GAL3) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 82-104% | 89-97% | 85-99% | 82-97% |
EDTA plasma(n=5) | 88-96% | 90-105% | 86-101% | 81-90% |
heparin plasma(n=5) | 99-105% | 94-101% | 88-97% | 95-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:GAL3) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Clinica Chimica Acta | Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population Pubmed:25578395 |
Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension PubMed: 25747153 |
Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension PubMed: 25984599 |
Scientifi Reportcs | Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices PubMed: 26582585 |
Clin Chim Acta | Galectin-1 and galectin-4: Plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population PubMed: 25578396 |
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION | Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4. pubmed:28431936 |
昆明医科大学学报 | 半乳糖凝集素3 在COPD 和肺癌中的表达及其意义. 2095610X |
Archives of Medical Science | Can we define migraine patients with blood high-sensitivity C-reactive protein and galectin-3 levels in the emergency department? publication:305625095 |
Biosensors & Bioelectronics | A sensitive sandwich-type immunosensor for the detection of galectin-3 based on N-GNRs-Fe-MOFs@AuNPs nanocomposites and a novel AuPt-methylene blue nanorod. pubmed:29096363 |
Scientific Reports | The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction. pubmed:28827564 |
Clinica Chimica Acta | Galectin-3 in patients with coronary heart disease and atrial fibrillation Pubmed:29287900 |
Advances in Experimental Medicine and Biology | Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease Pubmed:29429028 |
FASEB Journal | Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure Pubmed: 30230922 |
american journal of physiology-heart and circulatory physiology | Macrophage galectin-3 enhances intimal translocation of vascular calcification in diabetes mellitus Pubmed: 32216615 |
Cardiology | Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation Pubmed: 32516780 |
AUSTRALIAN DENTAL JOURNAL | The effect of initial periodontal treatment on gingival crevicular fluid galectin©\3 levels in participants with periodontal disease 33378559 |
Cell Death & Disease | Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis 33771973 |
Int J Clin Pract | Serum Galectin©\3 Levels in Patients with Psoriasis 34137138 |
Phytomedicine | Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial … Pubmed:35405613 |
Medicine | Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive … Pubmed:35687771 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
APA303Ra01 | Active Galectin 3 (GAL3) | Cell culture; Activity Assays. |
RPA303Ra01 | Recombinant Galectin 3 (GAL3) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA303Ra01 | Polyclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IP. |
LAA303Ra81 | FITC-Linked Polyclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IF. |
LAA303Ra71 | Biotin-Linked Polyclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC. |
MAA303Ra24 | Monoclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IP. |
MAA303Ra23 | Monoclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IP. |
MAA303Ra21 | Monoclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IP. |
MAA303Ra22 | Monoclonal Antibody to Galectin 3 (GAL3) | WB; IHC; ICC; IP. |
SEA303Ra | ELISA Kit for Galectin 3 (GAL3) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA303Ra | Magnetic Luminex Assay Kit for Galectin 3 (GAL3) ,etc. | Magnetic Luminex Assay for Antigen Detection. |